Cell line · CVCL_1384

LS174T

Cancer cell line, Homo sapiens. Colon adenocarcinoma. 101 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. LS174T. Cell lines, record CVCL_1384. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1384

On this page

Cell line

As Cellosaurus gives it.

Name: LS174T
Accession: CVCL_1384
RRID: RRID:CVCL_1384
Synonyms: Ls174T, LS174t, Ls-174-T, LS-174-T, LS 174 T, LS-174T, Ls-174T, LS 174T, LS-174, LS174, Laboratory of Surgery 174T
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 58Y
Category: Cancer cell line
Diseases: Colon adenocarcinoma (NCIt C4349)
Derived from: Colon (in situ)
Cell type: Epithelial cell of colon
Parent: LS180 (CVCL_0397)
Secondary accessions: CVCL_D190
Entry created: 2012-04-04
Entry updated: 2025-04-10

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers101

Paper	Journal	Year	How we know	Source
Integrative Assessment of Teucrium Extracts: Phytochemical Profile, Nutritional-Mineral Composition, Biological Activities, and Toxicological Assessment In Vitro and In Vivo.	Chem Biodivers	2026	Its Methods give the RRID and name the line	PubMed
A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression.	Cancer Cell	2026	Its Methods give the RRID and name the line	PubMed
High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRASG12D colorectal cancer.	NPJ Precis Oncol	2026	Its Methods give the RRID and name the line	PubMed
ASCC3 promotes chemosensitivity in colorectal cancer cells.	Sci Rep	2026	Its Methods give the RRID and name the line	PubMed
CF10 Displays Improved Synergy with Oxaliplatin in TP53-Null and Wild-Type CRC Cells from Increased Top1cc and Replication Stress.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
L1TD1 promotes colorectal mucinous adenocarcinoma progression by enhancing ABCC3 mRNA stability.	Oncogene	2026	Its Methods give the RRID and name the line	PubMed
LNP-Mediated CF10 Delivery Selectively Enhances Potency to Colorectal Cancer Cells and Preserves the TS/Top1 Dual Targeting Mechanism.	ACS Appl Bio Mater	2026	Its Methods give the RRID and name the line	PubMed
MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis.	Neoplasia	2026	Its Methods give the RRID and name the line	PubMed
Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy.	Oncol Res	2026	Its Methods give the RRID and name the line	PubMed
CD276 immature glycosylation drives colorectal cancer aggressiveness and T cell mediated immune escape.	Cell Commun Signal	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 101

See all 101 papers

Relatives14

Relation	Cell line	Accession	Source
Parent	LS180	CVCL_0397	Cell lines
Derived from it	HyCyte LS174T KO-hCHST4	CVCL_F4E2	Cell lines
Derived from it	HyCyte LS174T KO-hIL22RA1	CVCL_F4E3	Cell lines
Derived from it	LINTERNA LS 174	CVCL_YJ85	Cell lines
Derived from it	LS174T-FX-R	CVCL_C4RY	Cell lines
Derived from it	LS174T-HM3	CVCL_0306	Cell lines
Derived from it	LS174T-HM7	CVCL_6670	Cell lines
Derived from it	LS174T-LM12	CVCL_B6NS	Cell lines
Derived from it	LS174T-W4	CVCL_J074	Cell lines
Derived from it	LS174T/R	CVCL_A5BI	Cell lines

1 to 10 of 14

See all 14 relatives

Cell banks14

Cell bank	Catalog number	Status	Source
ATCC	CCL-188	Discontinued	Cellosaurus
ATCC	CL-188		ATCC
AddexBio	C0009013/379		Cellosaurus
BCRC	60053		BCRC
CCTCC	GDC0135		Cellosaurus
CLS	300392		CLS
DSMZ	ACC-759		DSMZ
ECACC	87060401		ECACC
KCB	KCB 200829YJ		Cellosaurus
KCLB	10188		KCLB

1 to 10 of 14

See all 14 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1384

GET https://conductscience.org/api/cell-lines/v1/CVCL_1384/papers?page=2

API reference For AI assistants